Thomas Andrew Rowland insider trades: Ani Pharmaceuticals (ANIP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ANIP | ↓ Sell | 459 | $79.21 | $36K | Direct | May 13, 2026 (1d) |
| Aug 12, 2025 | ANIP | ↓ Sell | 4,975 | $85.71 | $426K | Direct | Aug 14, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANIP insiders
Open-market trades in the last 12 months
About Thomas Andrew Rowland's insider trades
Thomas Andrew Rowland is SVP, Head - Established Brands at Ani Pharmaceuticals (ANIP). Since Aug 12, 2025, Thomas has reported no open-market purchases and 2 sales worth $463K on SEC Form 4. In the last 12 months: 1 sale ($36K).
Their filings also include shares withheld for taxes (5 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.